PROJECT DESCRIPTION
COVID-19 Vaccine hesitancy needs to be addressed
Developing a safe and efficacious vaccine against COVID-19 in record time has been a success, but swift and comprehensive rollout of the vaccine has been marred by a number of challenges.
On the supply side, these include funding, accessibility, and the logistical complexity of transporting, storing, and administering vaccines. On the demand side, one key challenge is vaccine hesitancy and resistance. Low confidence in COVID-19 vaccines, and low willingness to receive them, is a significant and growing risk to beating the pandemic globally.
79
%
OF RESPONDENTS WOULD TAKE A COVID-19 VACCINE
4-38
%
VACCINE
HESITANCY RANGE
48.2
%
AGREED TO VACCINATE ON ITS AVAILABILITY
Rollover Option 1
PROJECT APPROACH
Psycho-behavioral segmentation methodology
Follow along with us as we move through the different stages of this project from developing an in-depth understanding of the problem context to supporting the implementation of interventions. The stage we are currently working on is highlighted here.
Roll over each step to learn more
Research
2
Research
Understand the COVID-19 context, drivers and barriers to vaccine uptake through formative qualitative research. Then measure the prevalence, variations and clustering of drivers and barriers to COVID-19 vaccine in the population through quantitative segmentation.
Design Research and Outputs
3
Design Research and Outputs
Co-create and prioritize solution concepts with key stakeholders. Test concepts with psycho-behavioral segments and health system stakeholders. Synthesize findings in the creation of a design blueprint.
Research
Planning
1
Research Planning
Engage with various stakeholders and partners to understand the context, needs, and gaps in knowledge. Build partnerships and alignment on problem-framing and field recruitment.
Dissemination and Support
4
Dissemination and Support
Embed project research learnings within public health systems to ensure effective deployment of solutions.
